Member Info for B2HS2L

Shaun, this 2002 news item about British Airways loss of FTSE100 membership might assist, but might be a little out of date:
http://news.bbc.co.uk/1/hi/business/2248443.stm

Routy1,
Yes indeed, - it is also the case that on October 5th, AZN got a £152mil contract -
"AstraZeneca will create a clinical diagnostic centre to provide Covid-19 detection testing
to support the UK response to Covid-19.
This centre will be based in Cambridge, UK.
This service includes the analysis of swabs and all associated consumable expenses.
Throughout the contract, services will be scaled to support Covid-19 testing specifically."
++++
Having established the test centre earlier in the year, this contract was to increase the throughput at Cambridge test centre.

AZN will be buying COVID H-T test kits with some of this money, - and they will now need more of them.

I have been trying to find why Primerdesign and Lab21 are separately identified in the page 2 Financial Summary of the Numis report today, but not Microgen.

For the avoidance of doubt, - from 17th Sep 2020 RNS - Half year 2020 results :

Protein diagnostics

During H1 2020, the Company's protein diagnostics business, comprising of Lab21 Healthcare and Microgen Bioproducts, was significantly influenced by the COVID-19 pandemic and saw a reduction in global demand for its products.
++++
So Novacyt reports Microgen figures in with Lab21.

So in the NUMIS report (dated 16.10.2020) Financial Summary - page 2, Company Specific data:
Lab21 2019A = 6.8 2020E = 4.4 2021E = 5.2 2022E = 6.0 representing future estimations for Lab21 *AND* Microgen, because Microgen is not separately listed.

Microgen have launched 5 new products, and also the SARS-CoV-2 IgG EIA.

So it would appear that NUMIS are saying these new Microgen products will have little effect on this side of the business, or am I misreading things please?

Thermaxis - One further finding:

The innovative LightCycler® 1536 Multiwell Plate (1536-well format) is based on unique Thermaxis® technology and is manufactured under licence from IT-IS International Limited, under Patent Number US 60/970401.
2009 source -
https://www.ddw-online.com/1536-plate-progress-done-deal-but-difficult-transition-1002-200910/

Wondering what sort of income this has provided since 2009?

Hi Shaun,
wrt the DTI grant, please view the copyright at the bottom of the screen, - 2018, so grant might be even earlier.
Graham won't be alone long, I think assigning new directors is one of his very next steps, & the old directors will remain suitably motivated by the earnout. What the changes will cost might be interesting, - not easily budgeted beforehand.

wrt the LightCycler 1536 Multiwell Plate, looks like Roche have been a buyer of Thermaxis technology, according to this 2009 document:
https://lifescience.roche.com/content/dam/RMS/lifescience/Documents/PDF/High-Throughput-Analysis-Using-the-LightCycler-1536-Real-Time-PCR-System.pdf
Hoping we enjoy a sunny weekend, - we all need to get away from the screen.

ShaunP, - Here is another valid IT-IS website for the spreadsheet, - www.itisint.com
It provides information on the R&D projects this company has been focusing on.

On another note, the following link provides notice of recent changes of directors for IT-IS International.

https://find-and-update.company-information.service.gov.uk/company/05098475/officers

GM features in the driving seat now, and with all our best wishes for change implementation that he will have to bring about in as short a time as possible.

Agreed Simple00,
Graham being well acquainted with IT-IS would have known that an order of 300 or 700 would give IT-IS a big headache.
Now he can re-assign non-Novacyt customers instruments to NHS.
IMO the Govnt may have wanted 1000 now.

1000 now, - why so?
One possibly might be because of the inability of AVCT to supply spit on a stick LFT's that Boris has had a fruitless wait for???

This is just a thought guys, but the straw that broke the Camels back might have been the last Contract we picked up.
Why 300 instruments now and 700 later?
300 was all that was available, and (from GM's perspective - as supply was becoming an issue) hopefully 700 later?
Buying IT-IS was a bullet GM became more and more certain he was going to have to bite IMO.

It is just like GM to start taking specifications from others, so that manufacturing his own instruments is subsidised with profits from new customers.

If I am correct, and one of the reasons for buying IT-IS was that it looked increasing likely they would not be able to keep up with orders, then Graham is going to have to throw a bit more money at this to get production capacity where he wants it.
But he now has the capability to modify q16 / q32, or develop his own instruments in future, being his own master now.
We can only wish him well in achieving his new aims.

Original Nova - The q16 / q32 are central to NCYT's offering wrt Near Patient Testing.
I'm sure quite a few were happy to keep buying from a tried and tested supplier.

Now that more and more unit orders are being considered, is it possible that BoD might have seen IT-IS was not able to supply in the quantities and timescales.

Could it be IT-IS was being approached ref T/O from another company?

Both are possibilities, so what might Graham do about that situation?

In the same way that debt clearance was his first priority when cash started rolling in, security of supply was another high priority, particularly as imminent contracts might also require the availability of more q16 / q32 instruments.
(We supply 130 nations with instruments and associated test kits).

Does Graham start telling hot prospects he cannot supply these instruments?

It is great that supply issues have been addressed, particularly now that Novacyt customers might be getting these units at the expense of non-Novacyt customers who will now have to wait longer than they thought.

Just My 2cents

Tonights caption competition to with the below image:
https://www.businesswire.com/news/home/20200812005519/en/Rishi-Sunak-Visits-UK-Manufacturer-of-COVID-19-Analysis-Equipment

"I'm surprised. - I thought these £ billions would be going into a much bigger black hole...
I'll be late for the bus..."

++++
Shaun, - What part of the business is in Ireland do you know please?

Has removed a big threat to NCYT NPT progress, by ensuring no other interested party buys IT-IS.

Good News RNS.
Gives NCYT the opportunity to alter the priorities of IT-IS customer orders should q16 and q32 instrument sales be needed for further UK Govnt orders, etc.

If 300+700 instruments are not enough, no problem.

If a q64 is needed, we have the money and expertise to build it.

Wouldn't a q64 be good for assay sales...
YeeeeeeHaaaaa.

Thanks muchly Sparkle.
For me, your explanation, and the efforts of many other posters was necessary because the RNS was too damn long and not structured enough.
RM, - must try harder, - Plebeian chunks next time, - not everyone has a brain the size and complexity of an African termite mound.

Sounds like the riverside is a good place for a socially distanced all day barbie / picnic next year.
Would prefer it if we didn't need the distancing, but good luck to all holders.
It is amazing to me that many cannot see the value in holding this long term..

13th October Reuters report:
https://uk.reuters.com/article/uk-health-coronavirus-rapid-tests/countries-turn-to-rapid-antigen-tests-to-contain-second-wave-of-covid-19-idUKKBN26Y2P2?il=0

From poster gkb47 on AVCT bb:

Plenty of background information concerning NCYT competitors in Europe, and European countries testing news.

"Germany, where infections jumped by 4,122 on Tuesday to 329,453 total, has secured 9 million so-called antigen tests per month that can deliver a result in minutes and cost about 5 euros ($5.90) each. That would, in theory, cover more than 10% of the population."

Shaun, fodder for the spreadsheet perhaps.

..... and a company.

Pennant International Group Plc Ord 5P is listed on the London Stock Exchange, trading with ticker code PEN. It has a market capitalisation of £14m, with approximately 36m shares in issue.

Thanks Timster, I wondered why it was not reported here today, - my apologies.

Courtesy of Temuchin on NCYT bb.
https://www.express.co.uk/news/uk/1333686/Coronavirus-testing-latest-plan-covid-19-tests-boris-johnson

Apologies if posted before